Robert Thomas Freeman, Chief Financial Officer at Alignment Healthcare, Inc. (ALHC), sold 30,500 shares at $11.50 ($351K) on 2024-10-14, disclosed to the SEC on 2024-10-16.
Scheduled sale ($351k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ALHC | SELL | 2025-03-13 | $450K | — | Filing → |
| ALHC | SELL | 2025-03-06 | $10.7M | — | Filing → |
| ALHC | SELL | 2024-11-13 | $409K | — | Filing → |